Loading clinical trials...
Loading clinical trials...
Double Blind, Placebo-controlled Study to Assess the Effects of Erythropoietin on Clinical Disability and Brain Pathology as Shown by Magnetic Resonance Imaging in Patients With Progressive Multiple Sclerosis
Conditions
Interventions
Erythropoietin
Locations
1
Denmark
Karen Schreiber
Copenhagen, Oesterbro, Denmark
Start Date
November 1, 2009
Primary Completion Date
December 1, 2012
Completion Date
April 1, 2013
Last Updated
August 8, 2011
Lead Sponsor
Rigshospitalet, Denmark
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions